Phase 1 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with a specific type of leukemia called Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia (Ph+ B-ALL), where certain genetic abnormalities can still be detected
- People whose leukemia is currently in remission, meaning fewer than 5% of abnormal cells (blasts) are found in the bone marrow
- People who are in reasonably good general health and able to carry out daily activities (confirm with trial site for exact fitness level required)
- People whose major organs such as the liver, kidneys, and heart are functioning well enough to meet the trial's requirements
Who may not be able to join:
- People whose leukemia has come back and is active, with more than 5% abnormal cells (blasts) present in the bone marrow
- People who have developed a moderate to severe immune reaction called graft-versus-host disease (GVHD) after a transplant, which is currently being treated with steroid medications
- People who have serious problems with how their major organs are working, or who have an infection that is not currently under control
- People who are pregnant or currently breastfeeding
- People who have previously received an experimental CAR T-cell therapy as part of another clinical trial or investigational treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rawan Faramand, MD, Moffitt Cancer Center
Phone: 813-745-3178
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recommended Phase 2 Dose
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.